Orphan Drugs: Hope for rare disease communities Orphan drug monitoring emerges as a critical lifeline for rare diseases, offering hope to patients with uncommon medical conditions.
Safety monitoring of orphan drugs: The SFDA experience The safety of orphan drugs is hard to monitor as they target rare diseases afflicting small patient populations. However, an initiative led by the SFDA aims to improve this.
